Skip to main content
Tetra Bio-Pharma Inc. logo

Tetra Bio-Pharma Inc. — Investor Relations & Filings

Ticker · TBPMQ ISIN · CA88166Y1007 LEI · 5299000CYH3P8XC2UO53 TSX Manufacturing
Open in API
Filings indexed 720 across all filing types
Latest filing 2020-05-12 AGM Information
Country CA Canada
Listing TSX TBPMQ

About Tetra Bio-Pharma Inc.

https://tetrabiosciences.com/

Tetra Bio-Pharma is a biopharmaceutical company specializing in the discovery and development of cannabinoid-derived drugs and medicinal plant-based products. The company maintains an advanced pipeline encompassing biopharmaceuticals, natural health, and veterinary products. Clinical programs are focused on therapeutic areas such as inflammation, pain management (including alternatives to opioids), and ophthalmology. Tetra emphasizes rigorous clinical trials and scientific evidence, utilizing novel approaches, unique mechanisms of action, and high-quality delivery methods to address unmet patient needs.

Recent filings

Filing Released Lang Actions
Notice of meeting - English.pdf
AGM Information Classification · 100% confidence The document is a notice for the Annual General and Special Meeting of Shareholders of Tetra Bio-Pharma Inc. It details the date, time, and virtual format of the meeting, the agenda items including presentation of annual audited financial statements, election of directors, appointment of auditors, and other shareholder matters. It also references the management information circular and proxy voting instructions. The document does not contain the actual annual report or financial statements but serves as a formal meeting notice to shareholders. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting. The document length is 6777 characters, which is consistent with a detailed meeting notice rather than a full report. Therefore, the correct classification is AGM Information (AGM-R).
2020-05-12 English
Other.pdf
AGM Information Classification · 95% confidence The document is a detailed user guide for participating in a virtual Annual General Meeting (AGM). It provides instructions on how to join the meeting, vote, and ask questions online. There is no financial data, report content, or regulatory filing information. The document is clearly related to the AGM process and is a presentation or guide for shareholders to engage in the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length is under 5,000 characters, but it is not an announcement of a report publication; it is a guide for the AGM itself.
2020-05-12 English
Form of proxy - English.pdf
AGM Information Classification · 100% confidence The document is a Form of Proxy for the Annual General and Special Meeting of Tetra Bio-Pharma Inc. It includes instructions for appointing a proxyholder, voting methods, and voting recommendations on various agenda items such as election of directors, appointment of auditors, omnibus incentive plan, and share consolidation. It is clearly related to the AGM process and does not contain financial statements or detailed report content. The document is a proxy solicitation material for the AGM, which fits the category of AGM Information (AGM-R).
2020-05-12 English
Other.pdf
AGM Information Classification · 100% confidence The document is a Voting Instruction Form (VIF) related to the Annual General and Special Meeting of Tetra Bio Pharma Inc. It includes instructions for beneficial shareholders on how to vote their shares, proxy appointment details, and voting recommendations on various agenda items such as election of directors, appointment of auditors, omnibus incentive plan, and share consolidation. The document is clearly proxy-related material for an AGM, not the AGM presentation itself or the results of the vote. It does not contain financial statements or management discussion and analysis, but references these reports as available separately. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting.
2020-05-12 English
News release - English.pdf
Regulatory Filings
2020-05-11 English
News release - English.pdf
Regulatory Filings
2020-05-11 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.